CRT PREDICTS | Routine Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation | The British Heart Foundation (BHF) PROTECT-TAVI Trial

Sunday, March 9, 2025

10:40 AM – 11:00 AM ET

Moderator(s)

Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Panel Discussant(s)

Rajiv Gulati, MD, PhD

Chair, Division of Interventional Cardiology
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): No financial relationships to disclose
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Issam Moussa, MD

Medical Director, Carle Heart & Vascular Institte
Carle Health / University of Illinois Urbana Champaign
Dallas, Texas, United States

Disclosure(s): No financial relationships to disclose
Jeffrey J. Popma, MD

CRF
Newton, Massachusetts, United States

Disclosure(s): Medtronic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Chet Rihal, MD

Physician
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): Edward Lifesciences: Grant/Research Support (Ongoing)